ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

EXEL Exelixis Inc

23.1655
-0.6945 (-2.91%)
Mar 28 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 2,953,471
Bid Price 23.06
Ask Price 24.00
News -
Day High 23.98

Low
18.08

52 Week Range

High
24.34

Day Low 22.70
Company Name Stock Ticker Symbol Market Type
Exelixis Inc EXEL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.6945 -2.91% 23.1655 20:00:00
Open Price Low Price High Price Close Price Prev Close
23.90 22.70 23.98 23.73 23.86
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
17,893 2,953,471 $ 23.83 $ 70,373,405 - 18.08 - 24.34
Last Trade Time Type Quantity Stock Price Currency
18:10:49 1 $ 23.73 USD

Exelixis Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
7.19B 303.19M - 1.83B 207.77M 0.69 34.58
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Exelixis News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No EXEL Message Board. Create One! See More Posts on EXEL Message Board See More Message Board Posts

Historical EXEL Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week23.8224.0722.7023.782,074,420-0.6545-2.75%
1 Month22.0824.0721.8722.892,465,4591.094.92%
3 Months23.7424.0719.2022.142,376,981-0.5745-2.42%
6 Months22.1924.3418.6421.882,294,2410.97554.40%
1 Year18.5824.3418.0820.912,365,7014.5924.68%
3 Years22.5525.7714.8719.592,329,7930.61552.73%
5 Years23.3027.9013.6720.072,473,406-0.1345-0.58%

Exelixis Description

Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

Your Recent History

Delayed Upgrade Clock